NASDAQ:BEAM | Cash Flow Statement | Beam Therapeutics Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$122.68M
2026-03-31-$94.32M$5.61M-$128.51M$2.23M$25.27M$96.61M
2025-12-31$244.3M$5.67M-$83.29M$3.73M$108.41M$1.89M
2025-09-30-$112.73M
2025-06-30-$102.14M
2025-03-31-$108.33M$5.53M-$103.88M$3.07M-$125.09M$473.38M
2024-12-31-$90.35M$5.44M-$76.37M$2.97M$126.28M$3.44M
2024-09-30-$96.67M
2024-06-30-$91.05M
2024-03-31-$98.67M$5.43M-$99.75M$2.44M-$53.46M$2.9M
2023-12-31$142.8M$5.36M$135.07M$3.59M$98.1M$33.71M
2023-09-30-$96.09M
2023-06-30-$82.78M
2023-03-31-$96.46M$4.65M-$109.82M$6.02M$25.45M$98.42M
2022-12-31-$38.35M$3.94M-$69.19M$8.26M$113.44M$32.01M
2022-09-30-$109.58M
2022-06-30-$71.95M
2022-03-31-$69.21M$3.31M$218.49M$7.26M-$537.34M$55.68M
2021-12-31-$64.71M$2.63M$1.83M$13.37M-$77.5M$21.54M
2021-09-30-$28.12M
2021-06-30-$76.25M
2021-03-31-$201.56M$1.4M-$38.58M$11.48M-$279.63M$253.27M
2020-12-31-$95.46M$1.27M-$24.3M$8.13M-$81.43M$129.99M
2020-09-30-$34.45M
2020-06-30-$34.22M
2020-03-31-$30.46M$1.1M-$27.39M$3.05M-$76.79M$193.01M
2019-12-31-$27.85M-$17.8M$2.16M$16.56M$699,000.00
2019-09-30-$19.01M
2019-06-30-$17.86M
2019-03-31-$13.61M-$25.86M$2.35M-$2.35M$37.91M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$79.99M$22.29M-$345.1M$14.95M-$121.44M$478.05M
2024-12-31-$376.74M$21.93M-$347.25M$8.95M$185.01M$7.74M
2023-12-31-$132.53M$20.01M-$149.2M$33.73M$71.84M$276.45M
2022-12-31-$289.09M$14.15M$22.53M$48.95M-$461.34M$111.59M
2021-12-31-$370.64M$7.45M-$66.27M$46.81M-$294.14M$756.14M
2020-12-31-$194.59M$4.74M-$95.74M$16.36M-$100.12M$322.32M
2019-12-31-$78.33M$3.5M-$72M$12.52M-$66.66M$41.28M